Oxford Nanopore to Select First Users for Early Access to MinIon; Program 'Heavily Oversubscribed' | GenomeWeb

This article has been updated with additional information about the AGBT conference.

Oxford Nanopore Technologies said today that registration for early access to its MinIon sequencer has closed. It will now invite "a number of applicants" to be the first testers of the nanopore sequencing platform.

The company did not say how many early-access customers it will select for the first cycle of the program, which will run for six weeks, or when it will start sending them MinIon sequencers and consumables.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.